International Reflex Sympathetic Dystrophy Foundation

"Dedicated To Helping RSD Patients Worldwide"

Eric M. Phillips

P.O. Box 474

North Dighton, Massachusetts 02764-0474 USA

Phone: 774-501-2808  Fax: 774-501-2808



Office Hours

Monday through Friday

9:00 A.M. to 5:00 P.M. EST

(Please note our new mailing address and phone numbers)


Please view the following new topics: The Management of CRPS, Movement Disorders, Principles of Addiction, New Topics, Spread of CRPS, The Infusion Pump: Clinical Observation, Spine and the Autonomic Nervous System, Bone Scan and CRPS, CRPS and SCS, Dr.Ellen G. Wattay's Updated Manual for the Diagnosis and Treatment of RSD/CRPS I, Clinical Contribution To CRPS I, RSD Poems, RSD Stories, Clinical Trials: Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type I, CRPS and Sympathectomy, The National Disease Research Interchange (NDRI), Next Step O&P, Stages of CRPS/RSD, and Thermography Abstract.

Home Background About RSD Stages of CRPS/RSD RSD Puzzles #1-146 Management of CRPS Spread of CRPS Movement Disorders Principles of Addiction The Infusion Pump Spine and ANS Bone Scan and CRPS CRPS and SCS Cryotherapy Venipuncture CRPS Thermography Abstract Thermography Part - I Thermography Part- II Nerve Block Abstract CRPS - Sympathectomy Microcirculation Clinical Contribution On-line RSD Survey Printable RSD Survey RSD References RSD and Pregnancy Social Security Ruling RSD and SSDI Clinical Trials Dental Referrals Photonic Stimulator RSD Medical Articles RSD Articles List RSD Article #1 RSD Article #2 RSD Article #3 RSD Article #4 RSD Article #5 RSD Article #6 RSD Article #7 RSD Article #8 RSD Article #9 RSD Article #10 RSD Article #11 RSD Article #12 RSD Article #13 RSD Article #14 RSD Article #15 RSD Article #16 RSD Article #17 Anatomy Sketches RSD Manual For P.T.'s Medical Journal Links In The News Support Group Info RSD Events Links Language Translator Updates E-mail Search RSD Poems RSD Stories RSD Tissue Research Next Step O&P RSD Info Request Form New Topics Todd Rundgren Thank You!


In The News


This section of our website is where will post any news from around the world

regarding new medical treatments (new procedures or new medicines) for

the treatment of RSD/CRPS and chronic pain.


Study Finds Nerve Damage in Previously

Mysterious Chronic Pain Syndrome



FDA Public Health Advisory
Safety Warnings Regarding Use of Fentanyl Transdermal (Skin) Patches

FDA Asks Purdue Pharma to

Withdraw Palladone for Safety Reasons

Non-Narcotic Ziconotide Intrathecal Infusion (Prialt) for Severe Chronic Pain

On Dec. 28, the FDA approved ziconotide intrathecal (IT) infusion (Prialt, made by Elan Corporation, plc), for the management of severe chronic pain in patients for whom IT therapy is warranted, and who are intolerant or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or IT morphine.

The non-narcotic agent is the synthetic equivalent of a naturally occurring conopeptide found in a marine snail known as Conus magus, and is thought to work by blocking N-type calcium channels on nerves that transmit pain signals.

The approval was based on the results of three phase 3 clinical trials showing that ziconotide IT significantly reduced chronic pain in a variety of opioid-resistant patient populations with neuropathic pain and pain related to cancer and AIDS.

Adverse events were mild to moderate in intensity and included dizziness, ataxia, confusion, and abnormal gait.

Ziconotide IT is approved for use only in the Medtronic SynchroMed EL, SynchroMed II Infusion System, and Simms Deltec Cadd Micro External Microinfusion Device and Catheter.


This news story was posted on Medscape:


For further information:


Elan Corporation:



Journal of Clinical Pharmacology abstract:




The material on the IRSDF Homepage and all its associated, linked or reference pages is for informational and education purposes. It is not meant to take the place of your physician. Before starting, changing, or stopping any treatments or medicines consult your physician.
Eric M. Phillips, and Associates will not be held liable for any damage or loss as a result of information provided on this page or associated documentation. Again, this WEBSITE is simply published as an information source and should not be used to treat or make judgments on RSD. All material owned by others, that is distributed or published on this website, disk media, facsimile or copied through electronic or photographic means has been done so with the permission of the owner or author. Any and all material published in error, will be immediately removed or corrected upon notification of such. The IRSDF organization title known as the "International Reflex Sympathetic Dystrophy Foundation" and all associated material on this website may not be copied, reproduced or quoted without expressed written permission from the owner;   Copyright 1996-
2014   Eric M. Phillips- Last Update 2/1/2006


Louis Vuitton Outlet concord foamposites wolf grey 3s kate spade outlet louis vuitton outlet wolf grey 3s wolf grey 3s michael kors outlet michael kors outlet michael kors outlet jordan 3 sport blue coach factory online wolf grey 3s louis vuitton outlet sport blue 6s michael kors outlet sport blue 6s louis vuitton outlet louis vuitton outlet sport blue 6s